About Lustre Pharmaceutical
Lustre Pharmaceutical is a Healthcare company based in Ahmedabad (India) founded in 2001. It manufactures pharmaceutical tablets, capsules, syrups, and injections for health needs. It operates on a B2B model. Its Indian entity Lustre Pharmaceuticals Private Limited reported revenue of ₹10.03 Cr. Lustre Pharmaceutical offers products and services including Pharmaceutical Tablet, Pharmaceutical Capsule, Pharmaceutical Syrup, Pharmaceutical Injection, and Skin Care Products. Its focus areas include Pharmaceuticals, Franchise Distribution, PCD Pharma and Manufacturing. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Lustre Pharmaceutical Private Limited is a manufacturer of various pharmaceutical products, including tablets, capsules, syrups, and injections. Based in Ahmedabad, Gujarat, India, they produce high-quality medicines and offer franchise opportunities for distribution. The company focuses on supplying generic drugs and supports healthcare through reliable manufacturing processes, serving distributors and partners in the pharmaceutical industry.
- Headquarters Ahmedabad, India
- SectorsHealthcare
- Phone•••• ••••
- Website lustrepharma.com
- Legal Name Lustre Pharmaceuticals Private Limited
- Date of Incorporation 24 Mar, 2003
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹10.03 Cr
FY 2025 · +8% YoY
- Net Profit₹54.1 Lakh
FY 2025 · 5% margin
- EBITDA₹1.15 Cr
FY 2025 · 11% margin
Associated legal entities of Lustre Pharmaceutical
Lustre Pharmaceutical operates through Lustre Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lustre Pharmaceuticals Private Limited CIN U24231GJ2003PTC042154 | Active | 24 Mar 2003 | Ahmedabad, Gujarat | ₹10.0 Cr | 4 | View details |
Products & Services of Lustre Pharmaceutical
Lustre Pharmaceutical offers a comprehensive portfolio of products and services, including Pharmaceutical Tablet, Pharmaceutical Capsule, Pharmaceutical Syrup, Pharmaceutical Injection, and Skin Care Products.
Tablets for treating various health conditions
Capsules providing essential health supplements
Syrups for symptom relief and treatment
Injections for targeted therapeutic effects
Products for skin health and protection
Syrups delivering essential vitamins and minerals
Tablets for daily vitamin supplementation
Natural remedies based on traditional practices
Lotion for protection against sun damage
Products for heart health management
Board of directors of Lustre Pharmaceuticals Private Limited (Lustre Pharmaceutical)
Lustre Pharmaceuticals Private Limited is the primary company behind Lustre Pharmaceutical. The board of Lustre Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Jatinkumar Kantilal Modi, appointed in 2003. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jatinkumar Kantilal Modi DIN 01423270 | Director | 24 Mar 2003 | 23 yrs 7 mo | Lustre Pharmaceuticals Private Limited |
| Hirenkumar Knatilal Modi DIN 01485119 | Director | 24 Mar 2003 | 23 yrs 7 mo | Lustre Pharmaceuticals Private Limited |
| Shitalben Sanjykumar Modi DIN 01725110 | Director | 24 Mar 2003 | 23 yrs 7 mo | Lustre Pharmaceuticals Private Limited |
| Sanjaykumar Babulal Modi DIN 01423297 | Director | 20 Jun 2015 | 11 yrs 4 mo | Lustre Pharmaceuticals Private Limited |
Financials of Lustre Pharmaceutical
Figures of Lustre Pharmaceuticals Private Limited, the primary company behind Lustre Pharmaceutical, for FY 2025. Revenue was ₹10.03 Cr (+8% year on year). Net profit was ₹54.1 Lakh (5% margin). EBITDA was ₹1.15 Cr (11% margin). Revenue has grown at a compounded annual rate of +4% over three years and +8% over five years.
- ₹10.03 CrRevenue · FY 2025 · +8% YoY
- ₹54.1 LakhNet profit · 5% margin
- ₹1.15 CrEBITDA · 11% margin
- ₹1 LakhPaid-up capital
- +4%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Lustre Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Lustre Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Lustre Pharmaceutical
Lustre Pharmaceutical has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Lustre Pharmaceutical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lustre Pharmaceutical
Lustre Pharmaceutical was founded in 2001.
Lustre Pharmaceutical is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
The primary company behind Lustre Pharmaceutical, Lustre Pharmaceuticals Private Limited, reported revenue of ₹10.03 Cr for FY 2025, up 8% year on year.
Lustre Pharmaceutical Private Limited is a manufacturer of various pharmaceutical products, including tablets, capsules, syrups, and injections. Based in Ahmedabad, Gujarat, India, they produce high-quality medicines and offer franchise opportunities for distribution. The company focuses on supplying generic drugs and supports healthcare through reliable manufacturing processes, serving distributors and partners in the pharmaceutical industry.
Lustre Pharmaceutical's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Lustre Pharmaceutical offers Pharmaceutical Tablet, Pharmaceutical Capsule, Pharmaceutical Syrup, Pharmaceutical Injection, and 6 more products and services.
Lustre Pharmaceutical operates through Lustre Pharmaceuticals Private Limited.
The legal entities of Lustre Pharmaceutical currently have 4 directors, including Jatinkumar Kantilal Modi, Sanjaykumar Babulal Modi, Hirenkumar Knatilal Modi and others.